SOLUFERON
Table of contents:
The "SOLUFERON" trademark, serial number 79011624 , was filed on 31st of August 2004 with a mark drawing code of 4000 and its transaction date is 79011624. Since 20th of May 2014, the document can be found in the L90 law office in the publication and issue section. The employee responsible is ROSSMAN, MARY JO and the date it was published for opposition on 03/14/2006. The status of the trademark was checked last on 09/20/2013.
The "SOLUFERON" trademark, serial number 85796336 , was filed on 6th of December 2012 with a mark drawing code of 4000 and its transaction date is 85796336. The attorney assigned is Robert N. Cook, attorney docket number 12790001MA. Since 5th of February 2014, the document can be found in the M10 law office in the publication and issue section. The employee responsible is BENJAMIN, SARA NICOLE and the date it was published for opposition on 04/15/2014. The date when we last checked the status of this trademark was 08/11/2013.
Prior registrations: 3100973
The corresponded responsible for this trademark is ROBERT N. COOK, located at WHITHAM, CURTIS, CHRISTOFFERSON & COOK,, 11491 SUNSET HILLS RD STE 340, RESTON VA 20190-5244.The state or country where the trademark was organized is by Vakzine Projekt Management Gmbh. The legal entity type behing it is a Limited Liability Company, located at Mellendorferstraße 9, 30625 Hannover, zip .
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 12/17/2012 |
| Primary Code | 005 |
| International Class - 040 - Treatment of materials. | |
| U.S. Class | 106 - Material Treatment |
| Class Status | 6 - Active |
| Status Date | 12/17/2012 |
| Primary Code | 040 |
| International Class - 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. | |
| U.S. Class | 046 - Foods and Ingredients of Foods |
| Class Status | 6 - Active |
| Status Date | 12/17/2012 |
| Primary Code | 001 |
| International Class - 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 12/17/2012 |
| Primary Code | 042 |
| International Class - 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 12/17/2012 |
| Primary Code | 044 |
| International Class - 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. | |
| U.S. Class | 101 - Advertising and Business |
| Class Status | 6 - Active |
| Status Date | 07/23/2013 |
| Primary Code | 045 |
| Goods codes | |
| GS0011 | Chemical preparations for scientific and medical research purposes; protein for use in scientific and medical research; cultures of microorganisms and preparations derived therefrom for scientific and medical research purposes, namely, interferons and interferon-beta derivatives; cultures of microorganisms and preparations derived therefrom for laboratories, namely, interferons and interferon-beta derivatives; protein in a raw material form for scientific and medical research |
| GS0051 | Pharmaceutical and veterinary preparations, namely, immunomodulators; pharmaceutical and veterinary preparations, namely, interferon and interferon-beta derivatives for the treatment of infectious diseases or neurological disorders; pharmaceutical and veterinary products, namely, immunomodulators; pharmaceutical and veterinary products, namely, interferons and interferon-beta derivatives for treating diseases, namely, hepatitis infection, chronic obstructive pulmonary syndrome (COPD) and multiple sclerosis; cultures of microorganisms and preparations derived therefrom for medical or veterinary purposes, namely, interferons and interferon-beta derivatives for the treatment of infectious diseases and neurological disorders |
| GS0401 | Custom manufacture of pharmaceutical preparations; manufacture of pharmaceutical preparations to order; manufacture of pharmaceutical preparations for others; custom manufacture of immunomodulators; manufacture of immunomodulators to order; manufacture of immunomodulators for others |
| GS0421 | Scientific and technological services, namely, scientific and technological services related to interferons and interferon-beta derivatives in the nature of production, purification, formulation, product development, generation, mutation and derivatization and research relating thereto, namely, pharmaceutical research in the areas of virology, immunology, neurology, or pulmonology; services of chemists; services of biologists, biochemists or biotechnologists, namely, scientific research, pharmaceutical research, or product development; drawing up expert opinions relating to subjects from natural science or medicine, namely, scientific research, pharmaceutical research, or product development; scientific and technical project evaluations, namely, scientific product evaluations in the nature of product testing, pharmaceutical product evaluations, or product development evaluations in the nature of product testing; technical project management for research and development projects in the field of natural sciences or medicine; medical and scientific research, namely, conducting clinical and scientific studies; industrial chemical characterization, namely, chemical, physicochemical, physical and biological analysis, immunological response analysis, namely, determining humoral and cellular immune response and industrial research services in the field of pharmaceuticals; development of new technology and products for others on the basis of research results in the field of natural sciences and medicine |
| GS0441 | Medical services; veterinary sevices; pharmacists services to make up prescriptions; physician services; treatment of medical conditions; treatment of medical conditions using immunomodulators; treatment of medical conditions using interferon; medical diagnostic testing, monitoring and reporting services; providing medical information about viral disease, cancer diseases, diseases responsive to immunomodulators and diseases responsive to interferons |
| GS0451 | Exploitation of rights to results of research and pharmaceutical products, namely, patent licensing; licensing of intellectual property |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 02/05/2014 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 02/05/2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 02/05/2014 | TEAS REQUEST FOR RECONSIDERATION RECEIVED | I - Incoming Correspondence | ERFR | |
| 08/11/2013 | NOTIFICATION OF FINAL REFUSAL EMAILED | O - Outgoing Correspondence | GNFN | |
| 08/11/2013 | FINAL REFUSAL E-MAILED | O - Outgoing Correspondence | GNFR - FINAL REFUSAL E-MAILED | |
| 08/11/2013 | FINAL REFUSAL WRITTEN | R - Renewal | CNFR - FINAL REFUSAL WRITTEN | |
| 07/23/2013 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 07/22/2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 07/22/2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 07/22/2013 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 03/25/2013 | NOTIFICATION OF PRIORITY ACTION E-MAILED | O - Outgoing Correspondence | GPRN | |
| 03/25/2013 | PRIORITY ACTION E-MAILED | F - First Action | GPRA | |
| 03/25/2013 | PRIORITY ACTION WRITTEN | R - Renewal | CPRA - PRIORITY ACTION WRITTEN | |
| 03/25/2013 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 12/17/2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 12/10/2012 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.